Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|January 29, 2015
Less-tight versus tight control of hypertension in pregnancyLaura A Magee, Peter von Dadelszen, Evelyne Rey, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2016
The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?Laura A Magee, Peter von Dadelszen, Joel Singer, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 26, 2016
Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study)Marianne Vidler, Laura A Magee, Peter von Dadelszen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 13, 2015
Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trialL A Magee, , P von Dadelszen, et al.
American Journal of Obstetrics & Gynecology MFM|December 21, 2020
Perinatal death in a term fetal growth restriction randomized controlled trial: the paradox of prior risk and consentLinda van Wyk, Kim E Boers, Sanne J Gordijn, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 12, 2015
Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?L A Magee, , P von Dadelszen, et al.
Hypertension (Dallas, Tex. : 1979)|August 24, 2016
The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial)Rashid J Ahmed, Amiram Gafni, Eileen K Hutton, et al.
American Journal of Obstetrics and Gynecology|February 21, 2012
Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCTKim E Boers, Linda van Wyk, Joris A M van der Post, et al.
Pageof 21